{
    "code": "02022208",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022208",
    "time": "2021-10-22 07:36:36",
    "許可證字號": "衛署藥輸字第022208號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/06\/11",
    "發證日期": "87\/06\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202220800",
    "中文品名": "癲通錠２００毫克",
    "英文品名": "TEGRETOL TABLETS 200MG",
    "適應症": "癲癇症、三叉神經痛、腎原性尿崩症、雙極性極患、原發性舌咽神經痛。",
    "劑型": "110錠劑",
    "包裝": "20-1000錠 (SBC, Super Triplex)PVC\/PE\/PVDC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CARBAMAZEPINE",
    "限制項目": "02輸　入 1D須執行風險管理計畫",
    "申請商名稱": "1422701100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "": "ITALY",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812000400",
            "成分名稱": "CARBAMAZEPINE",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "022208_Tegretol 200mg_LFT-108-10-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022208&Seq=007&Type=9"
        },
        {
            "title": "Tegretol 200mg & CR 400mg_1230113_1230114 _TW _TA_p2_LFT_X-4-107-07-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022208&Seq=006&Type=9"
        },
        {
            "title": "癲通錠(三合一)-TWI-140518-回一校-107-05-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022208&Seq=005&Type=9"
        },
        {
            "title": "022208_Tegretol 200mg_FOIL-108-10-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022208&Seq=006&Type=8"
        },
        {
            "title": "022208_Tegretol 200mg_FB-108-10-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022208&Seq=005&Type=8"
        },
        {
            "title": "1223382_TW_TA_p1_FB_X-4-108-04-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022208&Seq=004&Type=8"
        }
    ]
}